PD-Rx Pharmaceuticals, Inc. has recalled approximately 1,969 bottles of Metformin Hydrochloride Extended-Release (HCL ER) 500 mg tablets, a prescription medication used to treat type 2 diabetes. This recall was initiated because FDA analysis found levels of N-Nitrosodimethylamine (NDMA) that exceed acceptable safety limits. While NDMA is a common environmental contaminant found in water and foods, it is classified as a probable human carcinogen if consumed at high levels over a long period. No injuries or illnesses have been reported to date, but consumers are advised to consult their healthcare providers as stopping this medication suddenly can pose serious health risks.
The tablets contain NDMA levels above the daily acceptable intake limit. NDMA is a substance that could increase the risk of cancer in humans if exposed to levels above safe limits over an extended duration.
Drug replacement and refund guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.